Back to discover
Drug

Triamcinolone hexacetonide

In clinical development
Emerging researchLate-stage development

Also known as Hexatrione, Triamcinolone.

1
Research papers
9
Active clinical trials
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Utilization of a Cutaneous Therapy In Situ Microdevice

Clinical trial2026-06-03Results expected Q2 2030 · ClinicalTrials.gov

The TRIBECA Study (TRIessence/Byqlovi for Easier CAtaract Surgery)

Clinical trial2026-03-31Results expected Q4 2026 · ClinicalTrials.gov

Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

Clinical trial2026-02-19Results expected Q4 2026 · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Triamcinolone hexacetonide
Aliases & brands
HexatrioneTriamcinolone
RxNorm CUI
38546

Clinical trials

90 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
90
registered trials across all phases
LATEST COMPLETION 2026
9
Active studies
8
Recruiting
72
Late-stage (III+)
51
Completed
30
Discontinued
PHASE DISTRIBUTIONn = 90
Early Phase 14Phase 12Phase 1 / 22Phase 210Phase 2 / 34Phase 311Phase 432Phase N / A25

Late-stage studies

Phase III+ trials still open or recently active — where late-stage evidence is being generated.

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

1 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Journals, researchers & institutions
Top journals
  • Ophthalmology1
Leading researchers
  • Aiello LP1
  • Antoszyk A1
  • Beck R1
  • Bressler N1
  • Browning D1
  • Chew E1
  • Danis R1
  • Fan J1
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials